Space company Maxar agrees to go private in $6.4 billion deal

Space company Maxar agrees to go private in .4 billion deal


Inside the company’s Palo Alto, California manufacturing facility,

Maxar

Space imagery and infrastructure company Maxar on Friday announced an agreement to go private through an acquisition led by Advent International.

The all-cash deal gives Maxar an enterprise value of about $6.4 billion. Private equity firm Advent is taking a $3.1 billion stake in Maxar, with British Columbia Investment Management Corporation also making a $1 billion equity contribution.

related investing news

Insider buying: SoFi's CEO makes another big move, while others scooped up falling stocks

CNBC Pro

“We’re really excited about it,” Maxar CEO Dan Jablonsky told CNBC. He said it would “allow us to invest even faster in the business, accelerate things like Legion seven and eight [satellites], and other technologies we’ve been developing.”

Shares of Maxar closed at $23.10 on Thursday, so the agreement with Advent at $53 a share represents a price nearly 130% above where the stock has recently traded.

Sign up here to receive weekly editions of CNBC’s Investing in Space newsletter.

Jablonsky has led a multi-year turnaround effort at Maxar since he was appointed CEO in January 2019, with the stock trading near $5 a share. The deal price with Advent is near the highs Maxar shares hit in early 2021, before dropping alongside other space stocks this year.

“We took a very hard and thoughtful look at all of the factors,” Jablonsky said. “This turned out to be the right transaction at the right time.”

A key aspect of Maxar’s agreement with Advent is a 60-day “go-shop period,” which ends on Feb. 14, for the company to consider alternative proposals.

Because of that, Jablonsky noted that it’s “still very early days” for what the future of Maxar would look like under Advent. He declined to comment on whether the new owners may look to carve out Maxar’s businesses, in satellite imagery and manufacturing – or whether he’ll stay on.

“Love what we’ve built and what we’re doing here and probably can’t say a lot beyond that right now,” Jablonsky said.



Source

Inside the booming business of wellness third spaces and membership clubs
Business

Inside the booming business of wellness third spaces and membership clubs

A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn’t have to involve alcohol. Newly sober and surrounded by friends who also chose not to drink, Guo said she wanted alternatives to the typical social scene. After some research, she landed on Bathhouse and Othership: […]

Read More
FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More